REVIEW
|
doi:10.20944/preprints202410.0644.v1
Subject:
Urology And Nephrology,
Medicine And Pharmacology
Keywords:
malignant melanoma; urological cancers; risk factors; shared genetic mutations; lifestyle changes; personalized treatment; tumor mutational burden; angiogenesis inhibitors; checkpoint inhibitors
Online: 9 October 2024 (10:58:57 CEST)